JCN Newswire

Subscribe to JCN Newswire: eMailAlertsEmail Alerts
Get JCN Newswire via: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn

Related Topics: Wealth Management

News Feed Item

Eisai Listed In Global 100 Sustainability Index for Third Consecutive Year

Tokyo, Jan 23, 2015 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that it has been listed in the 2015 Global 100 Most Sustainable Corporations in the World (Global 100) Index, a global ranking by Canada-based media and investment advisory company, Corporate Knights, Inc. This marks Eisai's third inclusion on the list in as many years, and Eisai is the only company from Japan to be included in 2015.

The Global 100 Index evaluates the sustainability of approximately 4,000 of the world's major corporations based on various corporate initiatives in areas such as the environment, society and governance. Since 2005, those companies ranking among the world's top 100 have been announced each year at the World Economic Forum in Davos. The index is based on 12 key performance indicators, including energy productivity, innovation capacity, percentage tax paid, safety performance and leadership diversity, with the evaluations carried out based solely on data publicly disclosed in annual reports, corporate sustainability reports, or through other such channels. In this year's Global 100 Index, Eisai is the only Japanese company to be listed and ranks in 50th place overall.

The Eisai Group's corporate philosophy is to give first thought to patients and their families and increase the benefits that health care provides as well as address diverse healthcare needs worldwide. Guided by this philosophy, Eisai will continue to develop innovative new drugs and make them available to patients around the world as early as possible to fulfill its social responsibility and secure the trust of stakeholders.

About Eisai

Eisai Co., Ltd. (TSE: 4523; ADR: ESALY) is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: integrative neuroscience, including neurology and psychiatric medicines; integrative oncology, which encompasses oncotherapy and supportive-care treatments; and vascular/immunological reaction. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system. For more information about Eisai Co., Ltd., please visit www.eisai.com.

Source: Eisai

Public Relations Department,
Eisai Co., Ltd.

Copyright 2015 JCN Newswire. All rights reserved. www.japancorp.net

More Stories By JCN Newswire

Copyright 2008 JCN Newswire. All rights reserved. Republication or redistribution of JCN Newswire content is expressly prohibited without the prior written consent of JCN Newswire. JCN Newswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.